TRPM8 and neoplasm: Recent pharmacological investigations have validated that TRPM8 blockade can diminish tumor growth in colorectal cancer xenograft mice by downregulating the transcription of Wnt signaling regulators and tempering the activation of β-catenin, alongside its target oncogenes like C-Myc and Cyclin D1.